Original Research
Accepted on 30 Apr 2025
Comparative safety analysis of bevacizumab and alkylating agent in glioblastoma management -what have we learned recently?
in Neuropharmacology
Original Research
Accepted on 30 Apr 2025
in Neuropharmacology
Original Research
Accepted on 30 Apr 2025
in Psychology for Clinical Settings
Original Research
Accepted on 30 Apr 2025
in Hematologic Malignancies
Original Research
Accepted on 30 Apr 2025
in Radiation Oncology
Original Research
Accepted on 30 Apr 2025
in Children and Health
Policy Brief
Accepted on 30 Apr 2025
in Public Health Policy
Original Research
Accepted on 30 Apr 2025
in Public Health Policy
Original Research
Accepted on 30 Apr 2025
in Physical Neuroergonomics
Study Protocol
Accepted on 30 Apr 2025
in Implementation Science
Original Research
Accepted on 30 Apr 2025
in Extra-intestinal Microbiome
Original Research
Accepted on 30 Apr 2025
in Plant Abiotic Stress
Original Research
Accepted on 30 Apr 2025
in Clinical Microbiology
Original Research
Accepted on 30 Apr 2025
in Life-Course Epidemiology and Social Inequalities in Health
Original Research
Accepted on 30 Apr 2025
in Movement Science
Original Research
Accepted on 30 Apr 2025
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Original Research
Accepted on 30 Apr 2025
in Epilepsy